FilingSEC EDGAR8-K
Rocket Pharmaceuticals Adopts New Severance and Change in Control Program for Employees
· SEC accepted
StageInternal Policy
Filing content
The company adopted a new severance and change in control program providing benefits to eligible employees, including executive officers, in connection with qualifying terminations.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…